CHEK2 and urinary bladder carcinoma: By systematically reviewing published papers on the association of germline genes with bladder cancer risk and validating reported candidate genes in a large population‐based cohort, we confirmed the association for three genes at the study‐wise significance level (p < 0.0056), including CHEK2, ATM and BRCA2.